2024-04-29
Beijing Wehealth Technology Co., Ltd. (Wehealth), a technology innovation company incubated and invested in by BAHEAL Pharmaceutical Group, proudly announces the launch of the third-generation Heartpal ECG Recorder series. This new generation of Heartpal ECG Recorders not only meets the medical-grade requirements of 12-lead ECGs but also integrates the display interface directly into the device, making it more user-friendly and suitable for home use. It can comprehensively detect heart issues such as myocardial ischemia, arrhythmia, and myocardial infarction, giving heart disease patients valuable time for treatment.
The 3rd-generation Heartpal EKG Device is renowned for its lightweight, portability, and user-friendly design, allowing even non-medical personnel to use it effortlessly for ECG monitoring anytime, anywhere. The ECG recorder is equipped with features like "Doctor Image Interpretation" and video consultation, enabling users to connect with healthcare professionals with a single touch and receive expert clinical advice quickly. The product is featured by its ease of use, fast detection, and comprehensive functionality.
Ease of use: Self-monitoring is simplified with the integrated 12-lead electrodes, eliminating the need for traditional ECG wiring patches. This makes positioning and operating the device straightforward, facilitating easy ECG self-testing.
Fast Detection: The device is quick to use, requiring no external equipment or app downloads. Users can start measuring with a single button press, view real-time analysis results, and connect to video doctors with one touch.
Comprehensive functionality: Unlike single lead, 3-lead or 5-lead ECG devices on the market that can only monitor cardiac arrhythmia and irregular heartbeats, the 12-lead wireless ECG device can detect not only arrhythmias and irregular heartbeats but also identify myocardial ischemia, locate ischemic myocardial areas, and timely detect myocardial infarction. Its diagnostic capabilities are on par with hospital ECG equipment, making it comprehensive for detecting conditions like arrhythmias, myocardial infarction, coronary heart disease, and structural heart diseases.
After accurately, synchronously, and stably collecting 12-lead ECG data, the third-generation Heartpal ECG Recorder uploads it in real-time to a cloud platform. This data is monitored by a team of medical experts from an online hospital, providing 24/7 remote ECG alerts and health management. This ensures that individuals at risk of heart disease can detect issues early and receive better treatment in a timely manner.
As health awareness increases and technology continues to advance, home medical devices will become an essential part of family health management. The launch of the third-generation Heartpal ECG Recorder series demonstrates the significant role of technological innovation in practical applications, improving people's quality of life. This product brings more efficient, intelligent cardiac monitoring and a comprehensive, closed-loop health management solution to families, applying technological advancements to everyday life and setting a new trend in home health management.
The concept of "new productive forces" has set higher expectations for the development of the healthcare industry. In the pharmaceutical and healthcare sector, only by reshaping the value chain through technological innovation can we drive and achieve high-quality industry development. In the future, BAHEAL Pharmaceutical Group will continue to deepen its efforts in the medical and healthcare field, aiming to optimize medical scenarios and address unmet clinical needs. The company will leverage its resource advantages and collaborative capabilities to accelerate the transformation of high-quality medical achievements, continuously contributing to the innovative development of the industry.